US DOE to fund projects for production of Mo-99

5 January 2017

The US Department of Energy’s National Nuclear Security Administration (NNSA) has signed follow-on cooperative agreements with three projects to establish a reliable domestic source of molybdenum-99 (Mo-99) that will be produced without the use of highly enriched uranium (HEU).

The agreements are with Shine Medical Technologies, NorthStar Medical Radioisotopes and General Atomics.  Shine plans to produce Mo-99 from low-enriched uranium (LEU), but using sub-critical accelerator technology rather than a nuclear reactor, NNSA said. NorthStar is developing a method using a linear accelerator, while General Atomics is developing an LEU target fission technology.

NNSA’s support to the three projects is based on a 50/50% government/commercial cost-share basis, up to a total NNSA contribution of $25m to each project. Currently the USA does not produce Mo-99 and imports supplies from foreign producers, some of which use HEU in the production processes. The latest funding completes the full $25 million NNSA contribution to each project.



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.